Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Rates of PSA screening in PLCO

Principal Investigator
Name
Jonathan Shoag
Degrees
MD
Institution
New York Presbyterian Hospital Weill Cornell
Position Title
Resident Physician
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-179
Initial CDAS Request Approval
Nov 20, 2015
Title
Rates of PSA screening in PLCO
Summary
The PLCO trial randomized men to usual care or annual PSA screening and DRE. We would like to examine the rates of screening in the intervention arms and the control arms during and after the study using the HSQ. This will provide insight into PSA screening in the community, and provide additional context to the debate on PSA screening.
Aims

1. Determine the rate of screening in the PLCO participants following the trial and in the control arm during the study.
2. Understand the demographics of PSA screening in the community.

Collaborators

NA

Related Publications